Table 1.

Patient characteristics regarding initial prostate cancer stage and primary therapy from 43 patients

Variables	Value
Primary therapy
Radical prostatectomy n (%)	38/43 (88.4%)
Radiotherapy n (%)	5/43 (11.6%)
Age at primary therapy (years)
Mean/SD/median/range	60.3/6.1/60.0/74 - 46
Pathologic Gleason score at primary therapy n (%)
6	4/43 (9%)
7	21/43 (49%)
8	7/43 (16%)
9	9/43 (21%)
x	2/43 (5%)
pT-stage at primary therapy n (%)
T2	16/43 (37%)
T3	26/43 (61%)
T4	1/43 (2%)
pN-stage at primary therapy n (%)
pN0	27/43 (63%)
pN1	12/43 (28%)
pNx	4/43 (9%)
Positive surgical margin at primary therapy n (%)
R0	17/43 (39%)
R1	14/43 (33%)
Rx	12/43 (28%)
Initial PSA at primary therapy (ng/ml)
Mean/SD/median/range	16.4/14.83/10.9/4.2 – 24.96

Salvage-LND = Salvage lymph node dissection; SD = Standard deviation.

PSA = Prostate specific antigen (ng/ml).